A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells

Yongfeng Luo, Wei Xu, Hui Chen, David Warburton, Rachel Dong, Bangping Qian, Moisés Selman, Jack Gauldie, Martin Kolb, Wei Shi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Idiopathic pulmonary fibrosis is a severe chronic lung disease with a high mortality rate. Excessive TGFβ signalling is recognized as a central player in lung fibrosis. However, the related mechanisms remain unclear. Herein we used a novel Tbx4 lung enhancer-driven Tet-On transgenic system to inhibit TGFβ signalling in mouse lung-resident mesenchymal cells at different stages of bleomycin-induced fibrosis, by conditionally knocking out TGFβ receptor II or expressing a dominant-negative TGFβ receptor II. Abrogation of mesenchymal TGFβ signalling markedly attenuated bleomycin-induced fibrotic pathology, which was independent of altered early inflammation. Furthermore, a novel TGFβ downstream target gene P4HA3 (an α-subunit of collagen prolyl hydroxylase) was identified, and its expression was significantly increased in fibroblastic foci of both bleomycin-induced fibrotic mouse lungs and idiopathic pulmonary fibrosis patients' lungs. The relationship between activated TGFβ signalling, up-regulation of P4HA3 and increased hydroxyproline/collagen production was further verified in cultured lung fibroblasts. Moreover, inhibition of collagen prolyl hydroxylase by pyridine-2,5-dicarboxylate attenuated TGFβ-stimulated collagen production in both cultured fibroblasts and bleomycin-induced mouse lung fibrosis. These data indicate that increased expression and activity of collagen prolyl hydroxylase is one of the important mechanisms underlying TGFβ-mediated profibrotic effects. Inhibition of collagen prolyl hydroxylase may be a new, promising approach for preventing and treating pulmonary fibrosis.

Original languageEnglish (US)
Pages (from-to)384-394
Number of pages11
JournalJournal of Pathology
Volume236
Issue number3
DOIs
StatePublished - Jul 1 2015

Fingerprint

Prolyl Hydroxylases
Collagen
Bleomycin
Lung
Idiopathic Pulmonary Fibrosis
Fibrosis
Fibroblasts
Pulmonary Fibrosis
Hydroxyproline
Lung Diseases
Chronic Disease
Up-Regulation
Pathology
Inflammation
Mortality

Keywords

  • collagen prolyl hydroxylase
  • lung mesenchymal cells
  • pulmonary fibrosis
  • TGFβ signalling

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells. / Luo, Yongfeng; Xu, Wei; Chen, Hui; Warburton, David; Dong, Rachel; Qian, Bangping; Selman, Moisés; Gauldie, Jack; Kolb, Martin; Shi, Wei.

In: Journal of Pathology, Vol. 236, No. 3, 01.07.2015, p. 384-394.

Research output: Contribution to journalArticle

Luo, Y, Xu, W, Chen, H, Warburton, D, Dong, R, Qian, B, Selman, M, Gauldie, J, Kolb, M & Shi, W 2015, 'A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells', Journal of Pathology, vol. 236, no. 3, pp. 384-394. https://doi.org/10.1002/path.4530
Luo, Yongfeng ; Xu, Wei ; Chen, Hui ; Warburton, David ; Dong, Rachel ; Qian, Bangping ; Selman, Moisés ; Gauldie, Jack ; Kolb, Martin ; Shi, Wei. / A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells. In: Journal of Pathology. 2015 ; Vol. 236, No. 3. pp. 384-394.
@article{07f3de921e61492ea82311e4b58113fd,
title = "A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells",
abstract = "Idiopathic pulmonary fibrosis is a severe chronic lung disease with a high mortality rate. Excessive TGFβ signalling is recognized as a central player in lung fibrosis. However, the related mechanisms remain unclear. Herein we used a novel Tbx4 lung enhancer-driven Tet-On transgenic system to inhibit TGFβ signalling in mouse lung-resident mesenchymal cells at different stages of bleomycin-induced fibrosis, by conditionally knocking out TGFβ receptor II or expressing a dominant-negative TGFβ receptor II. Abrogation of mesenchymal TGFβ signalling markedly attenuated bleomycin-induced fibrotic pathology, which was independent of altered early inflammation. Furthermore, a novel TGFβ downstream target gene P4HA3 (an α-subunit of collagen prolyl hydroxylase) was identified, and its expression was significantly increased in fibroblastic foci of both bleomycin-induced fibrotic mouse lungs and idiopathic pulmonary fibrosis patients' lungs. The relationship between activated TGFβ signalling, up-regulation of P4HA3 and increased hydroxyproline/collagen production was further verified in cultured lung fibroblasts. Moreover, inhibition of collagen prolyl hydroxylase by pyridine-2,5-dicarboxylate attenuated TGFβ-stimulated collagen production in both cultured fibroblasts and bleomycin-induced mouse lung fibrosis. These data indicate that increased expression and activity of collagen prolyl hydroxylase is one of the important mechanisms underlying TGFβ-mediated profibrotic effects. Inhibition of collagen prolyl hydroxylase may be a new, promising approach for preventing and treating pulmonary fibrosis.",
keywords = "collagen prolyl hydroxylase, lung mesenchymal cells, pulmonary fibrosis, TGFβ signalling",
author = "Yongfeng Luo and Wei Xu and Hui Chen and David Warburton and Rachel Dong and Bangping Qian and Mois{\'e}s Selman and Jack Gauldie and Martin Kolb and Wei Shi",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/path.4530",
language = "English (US)",
volume = "236",
pages = "384--394",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells

AU - Luo, Yongfeng

AU - Xu, Wei

AU - Chen, Hui

AU - Warburton, David

AU - Dong, Rachel

AU - Qian, Bangping

AU - Selman, Moisés

AU - Gauldie, Jack

AU - Kolb, Martin

AU - Shi, Wei

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Idiopathic pulmonary fibrosis is a severe chronic lung disease with a high mortality rate. Excessive TGFβ signalling is recognized as a central player in lung fibrosis. However, the related mechanisms remain unclear. Herein we used a novel Tbx4 lung enhancer-driven Tet-On transgenic system to inhibit TGFβ signalling in mouse lung-resident mesenchymal cells at different stages of bleomycin-induced fibrosis, by conditionally knocking out TGFβ receptor II or expressing a dominant-negative TGFβ receptor II. Abrogation of mesenchymal TGFβ signalling markedly attenuated bleomycin-induced fibrotic pathology, which was independent of altered early inflammation. Furthermore, a novel TGFβ downstream target gene P4HA3 (an α-subunit of collagen prolyl hydroxylase) was identified, and its expression was significantly increased in fibroblastic foci of both bleomycin-induced fibrotic mouse lungs and idiopathic pulmonary fibrosis patients' lungs. The relationship between activated TGFβ signalling, up-regulation of P4HA3 and increased hydroxyproline/collagen production was further verified in cultured lung fibroblasts. Moreover, inhibition of collagen prolyl hydroxylase by pyridine-2,5-dicarboxylate attenuated TGFβ-stimulated collagen production in both cultured fibroblasts and bleomycin-induced mouse lung fibrosis. These data indicate that increased expression and activity of collagen prolyl hydroxylase is one of the important mechanisms underlying TGFβ-mediated profibrotic effects. Inhibition of collagen prolyl hydroxylase may be a new, promising approach for preventing and treating pulmonary fibrosis.

AB - Idiopathic pulmonary fibrosis is a severe chronic lung disease with a high mortality rate. Excessive TGFβ signalling is recognized as a central player in lung fibrosis. However, the related mechanisms remain unclear. Herein we used a novel Tbx4 lung enhancer-driven Tet-On transgenic system to inhibit TGFβ signalling in mouse lung-resident mesenchymal cells at different stages of bleomycin-induced fibrosis, by conditionally knocking out TGFβ receptor II or expressing a dominant-negative TGFβ receptor II. Abrogation of mesenchymal TGFβ signalling markedly attenuated bleomycin-induced fibrotic pathology, which was independent of altered early inflammation. Furthermore, a novel TGFβ downstream target gene P4HA3 (an α-subunit of collagen prolyl hydroxylase) was identified, and its expression was significantly increased in fibroblastic foci of both bleomycin-induced fibrotic mouse lungs and idiopathic pulmonary fibrosis patients' lungs. The relationship between activated TGFβ signalling, up-regulation of P4HA3 and increased hydroxyproline/collagen production was further verified in cultured lung fibroblasts. Moreover, inhibition of collagen prolyl hydroxylase by pyridine-2,5-dicarboxylate attenuated TGFβ-stimulated collagen production in both cultured fibroblasts and bleomycin-induced mouse lung fibrosis. These data indicate that increased expression and activity of collagen prolyl hydroxylase is one of the important mechanisms underlying TGFβ-mediated profibrotic effects. Inhibition of collagen prolyl hydroxylase may be a new, promising approach for preventing and treating pulmonary fibrosis.

KW - collagen prolyl hydroxylase

KW - lung mesenchymal cells

KW - pulmonary fibrosis

KW - TGFβ signalling

UR - http://www.scopus.com/inward/record.url?scp=84930483141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930483141&partnerID=8YFLogxK

U2 - 10.1002/path.4530

DO - 10.1002/path.4530

M3 - Article

C2 - 25779936

AN - SCOPUS:84930483141

VL - 236

SP - 384

EP - 394

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 3

ER -